0001508691-22-000001.txt : 20221021 0001508691-22-000001.hdr.sgml : 20221021 20221021092714 ACCESSION NUMBER: 0001508691-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221021 DATE AS OF CHANGE: 20221021 EFFECTIVENESS DATE: 20221021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NX Pharmagen Inc. CENTRAL INDEX KEY: 0001508691 IRS NUMBER: 272135794 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462445 FILM NUMBER: 221322397 BUSINESS ADDRESS: STREET 1: 4350 BROWNSBORO ROAD STREET 2: SUITE 110 CITY: LOUISVILLE STATE: KY ZIP: 40207 BUSINESS PHONE: 502-741-5047 MAIL ADDRESS: STREET 1: 4350 BROWNSBORO ROAD STREET 2: SUITE 110 CITY: LOUISVILLE STATE: KY ZIP: 40207 D 1 primary_doc.xml X0708 D LIVE 0001508691 NX Pharmagen Inc. 4350 BROWNSBORO ROAD SUITE 110 LOUISVILLE KY KENTUCKY 40207 502-893-4570 DELAWARE None None Corporation true Brian Brohman 4350 Brownsboro Road Suite 110 Louisville KY KENTUCKY 40207 Executive Officer Director Robert Saunders 4350 Brownsboro Road Suite 110 Louisville KY KENTUCKY 40207 Director Alan Ezrin 4350 Brownsboro Road Suite 110 Louisville KY KENTUCKY 40207 Director Biotechnology Decline to Disclose 06b false 2022-10-10 false true false 0 1000000 590000 410000 false 19 0 0 0 false NX Pharmagen Inc. /s/ Brian D. Brohman Brian D. Brohman Chief Executive Officer 2022-10-21